Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder
Phase 4
Completed
- Conditions
- Substance AbuseBipolar Depression
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2007-03-19
- Target Recruit Count
- 30
- Registration Number
- NCT00203528
- Locations
- 🇺🇸
Tuscaloosa Research & Education Advancement Corporation, Tuscaloosa, Alabama, United States
Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use: A Placebo-Controlled Trial
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2012-09-03
- Target Recruit Count
- 20
- Registration Number
- NCT00203450
- Locations
- 🇺🇸
Tuscaloosa Research & Education Advancement Corporation, Tuscaloosa, Alabama, United States
Maintenance Phase Treatment With Divalproex for Post Traumatic Stress Disorder
Phase 4
Terminated
- Conditions
- PTSD
- Interventions
- Drug: Divalproex
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2017-04-26
- Target Recruit Count
- 20
- Registration Number
- NCT00203385
- Locations
- 🇺🇸
Tuscaloosa Research & Education Advancement Corporation, Tuscaloosa, Alabama, United States
Carbamazepine Extended-Release for the Treatment of Bipolar Depression
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2008-06-24
- Target Recruit Count
- 25
- Registration Number
- NCT00203567
- Locations
- 🇺🇸
Tuscaloosa Research and Education Advancement Corporation, Tuscaloosa, Alabama, United States
A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction
Phase 4
Completed
- Conditions
- HypercholesterolemiaHyperlipidemia
- Interventions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2014-08-12
- Target Recruit Count
- 30
- Registration Number
- NCT00203476
- Locations
- 🇺🇸
Tuscaloosa Research & Education Advancement Corporation, Tuscaloosa, Alabama, United States
© Copyright 2025. All Rights Reserved by MedPath